Overview

Single Dose Group Stratified Study in Renal Impaired and Healthy Aged and Gender Matched Subjects

Status:
Completed
Trial end date:
2014-08-14
Target enrollment:
Participant gender:
Summary
Safety, tolerability, pharmacokinetics and pharmacodynamics will be investigated in a single dose group stratified study in renal impaired and healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Bayer